Paradigm Biocapital Advisors’s Kyverna Therapeutics KYTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-50,000	Closed	-$1.24M	–	43
2024 Q1	$1.24M	Buy	+50,000	New	+$1.24M	0.04%	34